Compound 1077
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1ccc3OCOc3c1)c1c2[nH]n(-c2cccc(F)c2)c1=O
- InChi:
InChI=1S/C21H14FN5O3/c1-26-20-14(9-23-26)19-17(21(28)27(25-19)13-4-2-3-12(22)8-13)18(24-20)11-5-6-15-16(7-11)30-10-29-15/h2-9,25H,10H2,1H3
- InChiKey:
UJJLTAKKBBQNRE-UHFFFAOYSA-N
External links
![]() 168317915 |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.53 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 403.11 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 3.88 | |||
TPSA | 81.51 | |||
RB | 2 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4722 | Berberine | DB04115 | |
0.4680 | Riociguat | DB08931 | |
0.4615 | Merestinib | DB12381 | |
0.4599 | ATX-914 | DB12673 | |
0.4591 | Vericiguat | DB15456 | |
0.4361 | AZD-5423 | DB12280 | |
0.4326 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4321 | Neflamapimod | DB07138 | |
0.4309 | Dilmapimod | DB12140 | |
0.4292 | Tepotinib | DB15133 | |
0.4280 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4256 | MK-6186 | DB12999 | |
0.4254 | 1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine | DB08053 | |
0.4210 | MK-0249 | DB11910 | |
0.4204 | Ravoxertinib | DB15281 |